Zacks: Brokerages Expect NanoString Technologies Inc (NASDAQ:NSTG) Will Announce Earnings of -$0.59 Per Share

Wall Street analysts expect that NanoString Technologies Inc (NASDAQ:NSTG) will post earnings per share of ($0.59) for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for NanoString Technologies’ earnings. The highest EPS estimate is ($0.55) and the lowest is ($0.62). NanoString Technologies posted earnings per share of ($0.68) in the same quarter last year, which indicates a positive year over year growth rate of 13.2%. The company is scheduled to report its next quarterly earnings report on Thursday, March 5th.

On average, analysts expect that NanoString Technologies will report full-year earnings of ($2.48) per share for the current fiscal year, with EPS estimates ranging from ($2.52) to ($2.45). For the next financial year, analysts expect that the firm will report earnings of ($2.42) per share, with EPS estimates ranging from ($2.63) to ($2.03). Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that follow NanoString Technologies.

NanoString Technologies (NASDAQ:NSTG) last posted its quarterly earnings data on Monday, November 4th. The biotechnology company reported ($0.64) EPS for the quarter, missing the consensus estimate of ($0.54) by ($0.10). The company had revenue of $30.60 million during the quarter, compared to the consensus estimate of $28.05 million. NanoString Technologies had a negative net margin of 72.30% and a negative return on equity of 118.32%.

A number of analysts have recently commented on NSTG shares. Zacks Investment Research upgraded NanoString Technologies from a “sell” rating to a “hold” rating in a report on Tuesday. Stifel Nicolaus started coverage on NanoString Technologies in a report on Thursday, November 14th. They set a “buy” rating and a $28.00 price objective for the company. ValuEngine upgraded NanoString Technologies from a “hold” rating to a “buy” rating in a report on Friday, November 1st. Finally, BidaskClub raised NanoString Technologies from a “hold” rating to a “buy” rating in a research report on Monday, November 25th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $29.00.

In other NanoString Technologies news, Director Charles P. Waite, Jr. sold 1,707 shares of NanoString Technologies stock in a transaction on Friday, September 13th. The shares were sold at an average price of $21.75, for a total value of $37,127.25. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO K Thomas Bailey sold 5,937 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $23.00, for a total transaction of $136,551.00. Following the sale, the chief financial officer now directly owns 5,937 shares in the company, valued at $136,551. The disclosure for this sale can be found here. Insiders have sold 64,197 shares of company stock valued at $1,570,126 in the last 90 days. 5.10% of the stock is currently owned by corporate insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. James Investment Research Inc. bought a new stake in NanoString Technologies during the second quarter worth about $25,000. Strs Ohio grew its stake in NanoString Technologies by 7.1% in the second quarter. Strs Ohio now owns 28,500 shares of the biotechnology company’s stock valued at $864,000 after purchasing an additional 1,900 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of NanoString Technologies by 101.8% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 946,219 shares of the biotechnology company’s stock worth $28,718,000 after purchasing an additional 477,313 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. acquired a new position in shares of NanoString Technologies during the 2nd quarter worth approximately $1,125,000. Finally, Nikko Asset Management Americas Inc. increased its position in shares of NanoString Technologies by 418.9% during the 2nd quarter. Nikko Asset Management Americas Inc. now owns 2,488,261 shares of the biotechnology company’s stock worth $75,519,000 after purchasing an additional 2,008,747 shares during the last quarter.

NSTG stock traded up $0.04 during trading hours on Thursday, reaching $26.49. 30,607 shares of the stock were exchanged, compared to its average volume of 428,875. The firm’s 50-day moving average is $23.65 and its 200-day moving average is $25.68. NanoString Technologies has a 12 month low of $13.26 and a 12 month high of $34.78. The company has a market cap of $962.07 million, a price-to-earnings ratio of -9.53 and a beta of 1.16. The company has a debt-to-equity ratio of 1.51, a current ratio of 4.73 and a quick ratio of 4.23.

NanoString Technologies Company Profile

NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.

Further Reading: How to Invest in Marijuana Stocks

Get a free copy of the Zacks research report on NanoString Technologies (NSTG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.